155 related articles for article (PubMed ID: 31603006)
1. Hormonal therapy in menopausal transition: implications for improvement of health-related quality of life.
Dotlic J; Nicevic S; Kurtagic I; Radovanovic S; Rancic B; Markovic N; Milosevic B; Gazibara T
Gynecol Endocrinol; 2020 Apr; 36(4):327-332. PubMed ID: 31603006
[TBL] [Abstract][Full Text] [Related]
2. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
3. Climacteric women at work: What lurks behind poor occupational quality of life?
Gazibara T; Rancic B; Radovanovic S; Kurtagic I; Nurkovic S; Kovacevic N; Dotlic J
Health Care Women Int; 2018 Dec; 39(12):1350-1365. PubMed ID: 29668349
[TBL] [Abstract][Full Text] [Related]
4. The hot flush: the enigma of the climacteric.
Sturdee DW
Climacteric; 2001 Mar; 4(1):1-3. PubMed ID: 11379372
[No Abstract] [Full Text] [Related]
5. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
[TBL] [Abstract][Full Text] [Related]
6. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
7. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status.
Travers C; O'Neill SM; King R; Battistutta D; Khoo SK
Climacteric; 2005 Mar; 8(1):56-62. PubMed ID: 15804732
[TBL] [Abstract][Full Text] [Related]
8. Quality of life impairment during the female menopausal transition is related to personal and partner factors.
Chedraui P; San Miguel G; Avila C
Gynecol Endocrinol; 2009 Feb; 25(2):130-5. PubMed ID: 19253110
[TBL] [Abstract][Full Text] [Related]
9. The impact of hormone therapy on health-related quality of life: longitudinal results from the Study of Women's Health Across the Nation.
Hess R; Colvin A; Avis NE; Bromberger JT; Schocken M; Johnston JM; Matthews KA
Menopause; 2008; 15(3):422-8. PubMed ID: 18467950
[TBL] [Abstract][Full Text] [Related]
10. Effects of physical and depressive symptoms on the sexual life of Turkish women in the climacteric period.
Yanikkerem E; Göker A; Çakır Ö; Esmeray N
Climacteric; 2018 Apr; 21(2):160-166. PubMed ID: 29345506
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in climacteric Chilean women treated with low-dose estrogen.
Aedo S; Schiattino I; Cavada G; Porcile A
Maturitas; 2008 Nov; 61(3):248-51. PubMed ID: 18818032
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
Yisma E; Eshetu N; Ly S; Dessalegn B
BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.
Heinemann K; Rübig A; Strothmann A; Nahum GG; Heinemann LA
J Womens Health (Larchmt); 2008 Sep; 17(7):1151-66. PubMed ID: 18774896
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of climacteric symptoms among two populations of mid-aged women.
Gazibara T; López-Picado A; Larroy C; Milic M; Markovic N; Fernández-Arias I; Marín-Martín C; Dotlic J
J Obstet Gynaecol; 2022 Aug; 42(6):2178-2184. PubMed ID: 35253592
[TBL] [Abstract][Full Text] [Related]
15. Experience of climacteric symptoms among 42-46 and 52-56-year-old women.
Jokinen K; Rautava P; Mäkinen J; Ojanlatva A; Sundell J; Helenius H
Maturitas; 2003 Nov; 46(3):199-205. PubMed ID: 14585522
[TBL] [Abstract][Full Text] [Related]
16. [Survey on characteristics of menopause of Chinese women with the age of 40-60 years at gynecological clinic from 14 hospitals].
Chen R; Yu Q; Xu KH; Xie MQ; Lei XM; Ren ML; Ruan XY; Ding Y; Fu SX; Yang X; Lin Y; Wang HL; Wu YY; Zhang SF; Guo XT
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):723-7. PubMed ID: 24406126
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with intensity of climacteric symptoms in Brazilian middle-aged women: a population-based household survey.
Lui-Filho JF; Pedro AO; Baccaro LF; Costa-Paiva L
Menopause; 2018 Apr; 25(4):415-422. PubMed ID: 29112595
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey.
Pacello P; Baccaro LF; Pedro AO; Costa-Paiva L
Menopause; 2018 Jun; 25(6):683-690. PubMed ID: 29381660
[TBL] [Abstract][Full Text] [Related]
19. A multinational study of sleep disorders during female mid-life.
Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
[TBL] [Abstract][Full Text] [Related]
20. The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36.
Schneider HP; Heinemann LA; Rosemeier HP; Potthoff P; Behre HM
Climacteric; 2000 Mar; 3(1):50-8. PubMed ID: 11910610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
